RVMD: Revolution Medicines, Inc. insider trading, 5% holders and institutional ownership

From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.

Insider trading

0 open-market buys totaling - and 13 sales totaling $4.14M in the last 180 days.

Insider sales

Trade dateInsiderRoleValue10b5-1 plan
2026-09-29Sandler Alan B.Officer$442Kyes
2026-09-29Sandler Alan B.Officer$325Kyes
2026-09-29Sandler Alan B.Officer$203Kyes
2026-09-29Sandler Alan B.Officer$244Kyes
2026-09-29Sandler Alan B.Officer$62Kyes
2026-09-25Mancini AnthonyOfficer$626Kyes
2026-09-25Cislini JeffOfficer$159Kyes
2026-09-24Mancini AnthonyOfficer$117Kyes
2026-09-22Anderson Elizabeth MDirector$175Kyes
2026-09-22Anderson Elizabeth MDirector$960Kyes
2026-09-22Anderson Elizabeth MDirector$512Kyes
2026-09-22Anderson Elizabeth MDirector$292Kyes
2026-09-22Anderson Elizabeth MDirector$20Kyes

Activist and 5% holders

FiledWhatHolderStakeChangeFiling
2026-08-14New 13G stakeBaker Bros. Advisors LP5.30%SEC
2026-08-1313G amendmentFarallon Capital Management, L.L.C.6.40%SEC
2026-08-13New 13G stakeJANUS HENDERSON GROUP Ltd.5.10%SEC

Get new insider and activist filings the morning after: daily alerts. Not investment advice.